Most “risky” assets have rallied sharply since the US election last week, and today’s news about progress towards a vaccine for COVID-19 has given them a further boost. While it is hard to judge just how long-lasting the effects of either development will prove, both arguably point to further gains in risky assets against a backdrop of a recovering global economy and continued support from policymakers.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.